Search for: "Pharmacia & Upjohn Company"
Results 1 - 20 of 33
Sorted by Relevance | Sort by Date
24 Nov 6:18 am
... verdict for punitive damages. Punitive damages require a finding of wanton and reckless conduct. The jury heard evidence that the drug companies' attempt to suppress the
concerns about negative side effects of hormone replacement therapy drug Prempro, namely breast cancer. Similar allegations have been leveled against Pfizer and Pharmacia and Upjohn in pending litigation over the drug Mirapex. Louisville, Kentucky attorney Will Nefzger is
handling cases for several clients ...
17 Dec, 2007 12:00 am
... . GenericsWeb researches and monitors patent publications to assist in developing generic pharmaceuticals. Although many generics companies see this as an essential component
of their development activities, some choose to focus on Orange Book listed patents ... expected to prevent any company other than Hetero from
launching a generic version of Tolterodine as a tartrate salt in the USA. It could also be a cause for concern by the innovator Pharmacia &
Upjohn, whose original product seemingly ...
3 Sep 7:18 am
... at levels and for things known by the company to be unsafe. Pfizer also allegedly recruited doctors by showering them with lavish gifts,
trips and money. Pfizer, whose subsidiary Pharmacia and Upjohn will plead guilty to violating ...
marketed Geodon, Zyvox and Lyrica. Although the fine is a record sum, it represents only about three weeks of sales for the company.
Interestingly, it was a former sales representative and five others who blew the whistle. The fine represents Pfizer's fourth settlement ...
2 Sep 6:40 am
... liability arising from the illegal promotion of certain pharmaceutical products, the Justice Department announced today. Pharmacia &
Upjohn Company has agreed to plead guilty to a felony violation of the Food, Drug and Cosmetic Act
for ... This civil settlement and plea agreement by Pfizer represent yet another example of what penalties will be faced when a pharmaceutical company puts profits ahead of patient welfare." "The size and seriousness of this resolution, including the huge criminal fine ...
2 Sep 12:15 pm
... from marketing drugs for uses that have not been approved by the FDA. According to the press release by the DOJ: Pharmacia &
Upjohn Company has agreed to plead guilty to a felony violation of the Food, Drug and Cosmetic Act
for misbranding Bextra ... an anti-inflammatory drug that Pfizer pulled from the market in 2005. Under the provisions of the Food, Drug and Cosmetic Act, a company must specify the intended uses of a product in its new drug application to FDA. Once approved, the drug may not ...
4 Apr, 2007 1:43 am
... Michael A. Sullivan, one of the authors of this whistleblower lawyer blog). The government's announcement was that Pharmacia &
Upjohn Company, Inc., a subsidiary of Pfizer, Inc., was charged with offering a kickback in
connection with the administration and distribution of its human growth hormone, Genotropin. Another Pfizer subsidiary, Pharmacia &
Upjohn Company LLC entered into a Deferred Prosecution Agreement with the Government for what the
government described as illegally ...
2 Sep 9:02 am
... company has now withdrawn from the market. The essence of the case revolves around the marketing practices of Pfizer and other drug
companies. The companies are accused of Medicare fraud as well as illegally market their drugs for conditions for which the drugs are not intended. The ... penalties under
the agreement. The company will also pay $1 billion in other civil fines. And, Pharmacia &
Upjohn Company, a Pfizer subsidiary, must plead guilty to violations of the Food, Drug, and Cosmetic
Act.
2 Sep 4:08 am
... related to Bextra and $1 billion in civil fines related to a number of medicines. In addition, a Pfizer subsidiary, Pharmacia &
Upjohn Company, will plead guilty to violating the Food, Drug, and Cosmetic Act for its promotion of
Bextra. ... in 42 states and the District of Columbia to settle state claims related to its promotional practices concerning Geodon. The company will pay $33 million to the settling states and will take a charge in that amount to third-quarter 2009 earnings.Additional web ...
3 Sep 11:07 am
... that it had reached an agreement with pharmaceutical giant Pfizer Inc., and its subsidiary Pharmacia & Upjohn Company, to settle allegations that the company unlawfully marketed
some of its prescription drugs. Pfizer agreed to pay a total of ... of Pfizer stemmed from information provided by six qui tam whistleblowers that provided insider information regarding
the company's wrongdoing. The False Claims Act allows for whistleblowers to receive a share of the government's settlement as a reward ...
2 Sep 1:26 pm
Pharmaceutical giant Pfizer, Inc., and its drug subsidiary Pharmacia & Upjohn Company, Inc. are paying $2.3 billion to settle the largest criminal and civil health care fraud action ever brought by the U.S. Department of Justice.
According the DOJ, six whistleblowers ('relators' in legalese) who filed qui tam lawsuits under the False Claims Act will collectively [...]
2 Sep 4:08 pm
News release: " American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn
Company Inc. (hereinafter together "Pfizer") have...
9 Nov 1:01 am
... Oct. 21, 2008, when Lilly said it would pay its penalties, to Oct. 12, the company's stock value went up 0.6 percent; the S& ... and
death. Pfizer bought Pharmacia & Upjohn in April 2003. From 2001 to the end of 2003, P&U,
first as an independent company and then as a unit ... Court In January 2009, Lilly was back in federal court. Prosecutors in Philadelphia
accused the company of earning hundreds of millions of dollars by illegally promoting its schizophrenia drug Zyprexa for the unapproved ...
23 Nov 11:53 pm
... jury ruled. Jurors found that the combination of Wyeth's Prempro and Pharmacia & Upjohn's
Provera menopause drugs was a substantial contributing factor in Donna Kendall' ... 11 years. The panel will hear evidence Nov. 23 on whether Wyeth and Upjohn should pay punitive damages over their handling of the drugs. Wyeth has ... and selling the drugs was hiding health risks was "wanton and reckless."
That makes the companies open to a punitive-damage award under Pennsylvania law. "An adequate warning would ...
2 Sep 6:57 pm
... today. The settlement, totaling $2.3 billion, is with pharmaceutical company Pfizer and its subsidiary, Pharmacia & Upjohn. According to the agreement, Pharmacia &
Upjohn will plead guilty to charges of fraudulently marketing Bextra, an anti- ... these medications. The $1 billion represents the largest
civil fraud settlement ever against a pharmaceutical company. The settlement agreement also calls for Pfizer to establish business procedures
aimed at preventing recurrence of the conduct ...
12 Nov 3:24 pm
... Johnson, Abbot Laboratories, Schering-Plough, AstraZeneca or any other Big Pharma company, you've seen and may know all too well that
layoffs ... U.S. Food and Drug Administration (FDA). This past September, Pharmacia & Upjohn, a
Pfizer subsidiary, agreed to plead guilty to off-label marketing practices ... experts predict that former employees will come forward to highlight wrongdoing within these
companies. Qui Tam lawsuits, or whistleblower suits, help the government identify illegal practices ...
30 Sep 12:29 am
... $3.7 million, a jury decided in Philadelphia, without yet deciding whether the company was at fault and should pay her. Jurors deliberated
about two hours and 15 ... 9,000 lawsuits over its menopause drugs, along with Pfizer's Pharmacia & Upjohn unit. The company has now lost five of eight trials over its hormone-replacement ... reaching juries in 2006.
Some of the verdicts were set aside, and others are on appeal. This is the company's third straight loss. More than 6 million women have taken
...
23 May, 2008 10:50 am
... not need to provide specific details of misconduct in claiming a company marketed a drug for an unapproved use. The government offered its
interpretation of the laws governing off-label lawsuits in the case Peter Rost, former vice president of marketing at Pharmacia &
Upjohn, brought against Pfizer over marketing of the human growth hormone Genotropin. While the government has declined to intervene in the
litigation, ...
16 May, 2007 10:34 am
... Philadelphia jury deliberated more than six hours today before finding Pharmacia & Upjohn
didn't adequately warn women about Provera's breast cancer risk ... , 2007 press release issued by Pfizer, a representative of the world's largest drug company said that the jury's verdict in the Simon case lacked foundation, and that there would ... s senior vice president and associate general counsel. "We
believe Pharmacia and Upjohn acted responsibly with respect to Provera and we therefore intend to
pursue ...
24 Nov 1:11 am
... Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. In that case, the plaintiffs claim that the drug company
defendant, convinced doctors and the public that menopause was a chronic disease that required hormone drug treatment by an agressive ... profits. Members of the jury said after the
trial that the evidence showed Pfizer units Wyeth and Pharmacia & Upjohn dismissed opinions that
their hormone replacement drugs cause cancer, according to the Plaintiff's lawyer. ...
16 Sep 8:08 am
... : Salvatore J. Zambri, Esquire According to an AP (9/16) report, Pharmacia and Upjohn, a
subsidiary of Pfizer, "has pleaded guilty to illegally promoting the pain killer ... a sentencing hearing on Oct. 16." All too often we hear about drug companies, insurers, and
other entities that put profits over people. Innovation is essential, but no company should ever seek money at the expense of public health and
well-being. Such conduct is reprehensible and dangerous. Access to justice through the civil ...
Search on: Blawgs.FM | BlawgSearch Google Co-op |
Blawg.com | Bloglines | Feedster | Google Blog Search |
Technorati | Google | MSN | Yahoo!